Literature DB >> 22048738

Tackling antibiotic resistance.

Karen Bush1, Patrice Courvalin, Gautam Dantas, Julian Davies, Barry Eisenstein, Pentti Huovinen, George A Jacoby, Roy Kishony, Barry N Kreiswirth, Elizabeth Kutter, Stephen A Lerner, Stuart Levy, Kim Lewis, Olga Lomovskaya, Jeffrey H Miller, Shahriar Mobashery, Laura J V Piddock, Steven Projan, Christopher M Thomas, Alexander Tomasz, Paul M Tulkens, Timothy R Walsh, James D Watson, Jan Witkowski, Wolfgang Witte, Gerry Wright, Pamela Yeh, Helen I Zgurskaya.   

Abstract

The development and spread of antibiotic resistance in bacteria is a universal threat to both humans and animals that is generally not preventable but can nevertheless be controlled, and it must be tackled in the most effective ways possible. To explore how the problem of antibiotic resistance might best be addressed, a group of 30 scientists from academia and industry gathered at the Banbury Conference Centre in Cold Spring Harbor, New York, USA, from 16 to 18 May 2011. From these discussions there emerged a priority list of steps that need to be taken to resolve this global crisis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22048738      PMCID: PMC4206945          DOI: 10.1038/nrmicro2693

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  8 in total

Review 1.  Development of daptomycin for gram-positive infections.

Authors:  F P Tally; M F DeBruin
Journal:  J Antimicrob Chemother       Date:  2000-10       Impact factor: 5.790

Review 2.  Marine natural products.

Authors:  John W Blunt; Brent R Copp; Murray H G Munro; Peter T Northcote; Michèle R Prinsep
Journal:  Nat Prod Rep       Date:  2010-12-13       Impact factor: 13.423

Review 3.  Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Authors:  David J Payne; Michael N Gwynn; David J Holmes; David L Pompliano
Journal:  Nat Rev Drug Discov       Date:  2006-12-08       Impact factor: 84.694

Review 4.  Human nutrition, the gut microbiome and the immune system.

Authors:  Andrew L Kau; Philip P Ahern; Nicholas W Griffin; Andrew L Goodman; Jeffrey I Gordon
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

5.  The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.

Authors: 
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

6.  Emerging viruses, emerging threat.

Authors:  B J Culliton
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

7.  Development of an educational resource on microbes, hygiene and prudent antibiotic use for junior and senior school children.

Authors:  Donna M Lecky; Cliodna A M McNulty; Niels Adriaenssens; Tereza Koprivová Herotová; Jette Holt; Patty Kostkova; Kyriakoula Merakou; Raffaella Koncan; Anna Olczak-Pienkowska; António Brito Avô; José Campos; David Farrell; Pia Touboul
Journal:  J Antimicrob Chemother       Date:  2011-06       Impact factor: 5.790

8.  Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship.

Authors:  Rebecca R Roberts; Bala Hota; Ibrar Ahmad; R Douglas Scott; Susan D Foster; Fauzia Abbasi; Shari Schabowski; Linda M Kampe; Ginevra G Ciavarella; Mark Supino; Jeremy Naples; Ralph Cordell; Stuart B Levy; Robert A Weinstein
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

  8 in total
  295 in total

1.  Antibiotics: Recover the lost art of drug discovery.

Authors:  Kim Lewis
Journal:  Nature       Date:  2012-05-23       Impact factor: 49.962

Review 2.  Multidrug evolutionary strategies to reverse antibiotic resistance.

Authors:  Michael Baym; Laura K Stone; Roy Kishony
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

3.  Assembly and clustering of natural antibiotics guides target identification.

Authors:  Chad W Johnston; Michael A Skinnider; Chris A Dejong; Philip N Rees; Gregory M Chen; Chelsea G Walker; Shawn French; Eric D Brown; János Bérdy; Dennis Y Liu; Nathan A Magarvey
Journal:  Nat Chem Biol       Date:  2016-02-01       Impact factor: 15.040

4.  Synthesis and biological evaluation of solithromycin analogs against multidrug resistant pathogens.

Authors:  Samer S Daher; Xiao Jin; Jimmy Patel; Joel S Freundlich; Bettina Buttaro; Rodrigo B Andrade
Journal:  Bioorg Med Chem Lett       Date:  2019-03-26       Impact factor: 2.823

5.  Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases.

Authors:  Neil R Stokes; Helena B Thomaides-Brears; Stephanie Barker; James M Bennett; Joanne Berry; Ian Collins; Lloyd G Czaplewski; Vicki Gamble; Paul Lancett; Alastair Logan; Christopher J Lunniss; Hilary Peasley; Stéphanie Pommier; Daniel Price; Carol Smee; David J Haydon
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

Review 6.  Can light-based approaches overcome antimicrobial resistance?

Authors:  Michael R Hamblin; Heidi Abrahamse
Journal:  Drug Dev Res       Date:  2018-08-02       Impact factor: 4.360

7.  Trends and correlation of antibacterial usage and bacterial resistance: time series analysis for antibacterial stewardship in a Chinese teaching hospital (2009-2013).

Authors:  Y M Zou; Y Ma; J H Liu; J Shi; T Fan; Y Y Shan; H P Yao; Y L Dong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-10       Impact factor: 3.267

8.  Stabilization of cooperative virulence by the expression of an avirulent phenotype.

Authors:  Médéric Diard; Victor Garcia; Lisa Maier; Mitja N P Remus-Emsermann; Roland R Regoes; Martin Ackermann; Wolf-Dietrich Hardt
Journal:  Nature       Date:  2013-02-21       Impact factor: 49.962

9.  Crystal structure and functional mechanism of a human antimicrobial membrane channel.

Authors:  Chen Song; Conrad Weichbrodt; Evgeniy S Salnikov; Marek Dynowski; Björn O Forsberg; Burkhard Bechinger; Claudia Steinem; Bert L de Groot; Ulrich Zachariae; Kornelius Zeth
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-20       Impact factor: 11.205

10.  Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone.

Authors:  Leonardo Neves Andrade; Lúcia Vitali; Gilberto Gambero Gaspar; Fernando Bellissimo-Rodrigues; Roberto Martinez; Ana Lúcia Costa Darini
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.